Connor, Clark & Lunn Investment Management Ltd. Exact Sciences Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 335,705 shares of EXAS stock, worth $19.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
335,705
Previous 210,513
59.47%
Holding current value
$19.3 Million
Previous $8.89 Million
157.0%
% of portfolio
0.12%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
674Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.02 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$909 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$822 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$692 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$383 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.2B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...